Diversified LLC Sells 315 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Diversified LLC cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 32.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 653 shares of the medical equipment provider’s stock after selling 315 shares during the quarter. Diversified LLC’s holdings in Intuitive Surgical were worth $220,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. OFI Invest Asset Management bought a new stake in shares of Intuitive Surgical in the third quarter worth approximately $25,000. Baystate Wealth Management LLC grew its position in Intuitive Surgical by 150.0% during the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 45 shares during the period. MCF Advisors LLC grew its position in Intuitive Surgical by 108.1% during the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after buying an additional 40 shares during the period. Headinvest LLC bought a new stake in Intuitive Surgical during the third quarter valued at approximately $28,000. Finally, Stone House Investment Management LLC grew its position in Intuitive Surgical by 100.0% during the third quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 50 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

ISRG has been the subject of several recent research reports. BTIG Research boosted their target price on shares of Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a research report on Friday. Stifel Nicolaus boosted their target price on shares of Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, April 8th. Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $363.00 to $416.00 and gave the company an “overweight” rating in a research report on Friday, January 19th. Raymond James lifted their price target on shares of Intuitive Surgical from $372.00 to $435.00 and gave the company an “outperform” rating in a report on Thursday, January 25th. Finally, Jefferies Financial Group lifted their price target on shares of Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a report on Friday. Five investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $396.17.

Check Out Our Latest Research Report on ISRG

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $368.93 on Tuesday. The firm has a fifty day moving average price of $386.57 and a 200 day moving average price of $344.41. Intuitive Surgical, Inc. has a fifty-two week low of $254.85 and a fifty-two week high of $403.76. The firm has a market cap of $130.77 billion, a price-to-earnings ratio of 66.59, a P/E/G ratio of 5.69 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last released its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The business had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. During the same quarter in the previous year, the company posted $1.00 EPS. The company’s revenue was up 11.5% compared to the same quarter last year. As a group, research analysts predict that Intuitive Surgical, Inc. will post 4.93 earnings per share for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, VP Marshall Mohr sold 108,790 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, February 28th. The stock was sold at an average price of $385.08, for a total value of $41,892,853.20. Following the sale, the vice president now owns 26,877 shares of the company’s stock, valued at approximately $10,349,795.16. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other Intuitive Surgical news, VP Marshall Mohr sold 108,790 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, February 28th. The stock was sold at an average price of $385.08, for a total value of $41,892,853.20. Following the sale, the vice president now owns 26,877 shares of the company’s stock, valued at approximately $10,349,795.16. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, VP Fredrik Widman sold 5,041 shares of Intuitive Surgical stock in a transaction that occurred on Friday, March 15th. The stock was sold at an average price of $397.07, for a total value of $2,001,629.87. Following the completion of the sale, the vice president now directly owns 110 shares in the company, valued at approximately $43,677.70. The disclosure for this sale can be found here. Insiders have sold a total of 248,418 shares of company stock valued at $95,927,097 in the last quarter. 0.80% of the stock is currently owned by insiders.

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Read More

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.